Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 02 - 23 symbols : Ppruf save search
Vaxcyte Doses First Participants in Phase 1/2 Clinical Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
Published: 2022-02-23 (Crawled : 22:00) - globenewswire.com
PPRUF | News | $358.55 1.5K
|
Consumer Non-Durables
|
| O: -8.77%
H: 6.66%
C: 5.47%
PPRUY | News | $36.0023 220K
|
Manufacturing
|
| O: -5.49%
H: 3.87%
C: 3.65%
PCVX | $61.67 1.73% 63K
|
Health Technology
|
| O: -8.4%
H: 22.28%
C: 21.9%
STRO M | $3.745 -0.66% 67K
|
Health Technology
|
| O: -1.09%
H: 8.21%
C: 8.09%
vax-24 disease phase 1 pneumococcal
AOTMP® Announces Women in Technology Focus in June Industry Publication
Published: 2022-02-23 (Crawled : 17:00) - prnewswire.com
PPRUF | News | $358.55 1.5K
|
Consumer Non-Durables
|
| O: 7.45%
H: 0.0%
C: -3.02%
PPRUY | News | $36.0023 220K
|
Manufacturing
|
| O: 0.24%
H: 0.09%
C: -2.73%
aotmp technology women publication
Ballard & ABB Receive Approval in Principle for High-Power Fuel Cell Concept to Power Ships
Published: 2022-02-23 (Crawled : 14:00) - prnewswire.com
PPRUF | News | $358.55 1.5K
|
Consumer Non-Durables
|
| O: 7.45%
H: 0.0%
C: -3.02%
PPRUY | News | $36.0023 220K
|
Manufacturing
|
| O: 0.24%
H: 0.09%
C: -2.73%
BLDP | $2.675 -0.56% 360K
|
Producer Manufacturing
|
| O: 2.43%
H: 2.21%
C: -4.63%
fuel cell approval cel
Gainers vs Losers
| 83% | 17% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0835 131.94% 160M
|
ZCMD | $2.18 50.35% 24M
|
Commercial Services
CHRO | $1.73 41.22% 46K
|
n/a
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.3174 31.1% 28M
|
Manufacturing
WISA 4 | $7.11 20.71% 4.7M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
LIFW | News | $0.99 19.26% 800K
|
Administrative and Support and ...
Your saved searches
Save your searches and get alerts when important news are released.